Northwire Canada EditionMonday, August 17, 2026
Northwire
TRO 0.130 +4.0% HDRO 1.51 +4.1% LOD 0.420 +5.0% GRZ 6.50 +0.0% ELBM 0.800 −1.2% AG 27.23 +1.8% PAAS 66.75 +1.4% GGM 0.035 +0.0% NTH 0.152 −4.7% SRC 1.76 −0.6% SAGE 0.150 +0.0% NIM 0.760 +4.1% LUCA 0.980 +2.1% SVM 16.53 −0.8% SRL 0.395 −3.7% CNL 20.31 −0.9% TRO 0.130 +4.0% HDRO 1.51 +4.1% LOD 0.420 +5.0% GRZ 6.50 +0.0% ELBM 0.800 −1.2% AG 27.23 +1.8% PAAS 66.75 +1.4% GGM 0.035 +0.0% NTH 0.152 −4.7% SRC 1.76 −0.6% SAGE 0.150 +0.0% NIM 0.760 +4.1% LUCA 0.980 +2.1% SVM 16.53 −0.8% SRL 0.395 −3.7% CNL 20.31 −0.9%
Financings

Pasinex closes Sarlkaya acquisition, schedules AGM

PSE · Price

Executive Summary

  • Pasinex Resources completed the acquisition of the Sarlkaya zinc project in Turkey, now holding 100 % of both Pinargozu and Sarlkaya operations.
  • The company changed its fiscal year‑end to March 31, filing a transitional 15‑month report covering Jan 1 2025 – Mar 31 2026.
  • Private placement financing has attracted over C$1.2 million of subscriptions out of a C$2.15 million target; proceeds will fund Sarlkaya development and general corporate purposes.

Key Details

  • Acquisition Completion: Pasinex Arama ve Madencilik A.S. acquired all outstanding shares of Aydın Teknik, making it the sole shareholder. The transaction includes a US$2 million pledge to sellers.
  • Project Profile: Sarlkaya hosts 30‑50 % high‑grade carbonate‑hosted zinc mineralization with near‑surface zones amenable to direct mining and upside potential from further drilling.
  • Financial Year‑End Change: Fiscal year-end moved from Dec 31 to Mar 31. A transitional audited report will cover Jan 1 2025 – Mar 31 2026 (15 months). Subsequent FY runs Apr 1 2026 – Mar 31 2027.
  • Board Nomination & AGM: Dr. Mehmet Komurcu (Dentons partner) to be nominated for election at the AGM on Nov 21 2025, 11:00 a.m. ET, Toronto. Record date set for Oct 17 2025.
  • Private Placement Update: Offering size C$2.15 million; subscriptions received >C$1.2 million to date. Closing expected in coming weeks. Net proceeds earmarked for Sarlkaya development and general corporate use.
  • Stock Option Grant: 2.5 million options granted on Sep 26 2025 to directors, officers, key employees; exercise price C$0.075 per share; vest immediately; expire five years from grant date.

Notable Quotes

“These past few months have been transformative for Pasinex… With the completion of the Sarlkaya acquisition, we now control two zinc projects in Turkey with complementary profiles…” – Larry Seeley, Executive Chairman.

Read the original news release →

More from Pasinex Resources Ltd